Crossmark

An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancer

Crossref DOI link: https://doi.org/10.1186/s12967-025-06731-9

Published Online: 2025-07-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Yongzheng

Xie, Wenlong

Wu, Guangzhen https://orcid.org/0000-0002-2300-8465
Funding

Funding for this research was provided by:

Dalian Life and Health Field Guidance Plan (2024ZDJH01PT068)

Natural Science Foundation of Liaoning Province (Natural Science Foundation of Liaoning Province)
License Information

Text and Data Mining valid from 2025-07-29

Version of Record valid from 2025-07-29
More Information

Article History

Received: 4 June 2025

Accepted: 5 June 2025

First Online: 29 July 2025

Declarations

:

: Not applicable.

: Not applicable.

: All authors declare to have no conflicts of interest relevant to this study.

Document is current

Any future updates will be listed below